FDA Inspection 1013498 — Celltrion Inc.
The FDA completed an inspection of Celltrion Inc. on Jun 2, 2017 in Yeonsu. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jun 2, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yeonsu (Korea (the Republic of))